Zenas Biopharma Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 08/13/2026 | 9.51 M | $241.28 M | 4.68% | 15.06% |
| SR ONE CAPITAL MANAGEMENT, LP | 08/12/2026 | 5.04 M | $127.86 M | 0.00% | 7.98% |
| NEA MANAGEMENT COMPANY, LLC | 08/14/2026 | 4.02 M | $102.11 M | 0.00% | 6.37% |
| ENAVATE SCIENCES GP, LLC | 08/14/2026 | 3.92 M | $99.47 M | 0.00% | 6.21% |
| FEDERATED HERMES, INC. | 08/12/2026 | 3.12 M | $79.10 M | -0.33% | 4.94% |
| BLACKROCK, INC. | 08/07/2026 | 2.69 M | $68.18 M | 31.84% | 4.26% |
| CAPITAL INTERNATIONAL INVESTORS | 08/12/2026 | 2.50 M | $63.52 M | 2.83% | 3.97% |
| POLAR CAPITAL HOLDINGS PLC | 08/14/2026 | 2.41 M | $61.24 M | -5.32% | 3.82% |
| ROYALTY PHARMA SUB-MANAGER, LLC | 08/21/2026 | 2.39 M | $60.61 M | 0.00% | 3.78% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 08/14/2026 | 2.36 M | $59.87 M | 0.00% | 3.74% |
| STATE STREET CORP | 08/07/2026 | 2.06 M | $52.16 M | 39.72% | 3.26% |
| NVP ASSOCIATES, LLC | 08/07/2026 | 1.84 M | $46.66 M | 0.00% | 2.91% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 1.59 M | $40.45 M | 27.91% | 2.53% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 1.35 M | $34.39 M | 8.79% | 2.15% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 1.23 M | $31.25 M | 217.03% | 1.95% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 1.23 M | $31.14 M | 243.42% | 1.94% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 1.10 M | $21.57 M | 22.96% | 1.75% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 882.65 K | $22.41 M | 34.60% | 1.40% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 815.15 K | $20.69 M | 196.36% | 1.29% |
| ECOR1 CAPITAL, LLC | 08/14/2026 | 789.50 K | $20.04 M | 0.00% | 1.25% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 660.47 K | $16.76 M | 38.52% | 1.05% |
| WOODLINE PARTNERS LP | 08/14/2026 | 590.54 K | $14.99 M | 0.00% | 0.94% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 576.72 K | $14.64 M | -13.54% | 0.91% |
| ARROWMARK COLORADO HOLDINGS LLC | 08/13/2026 | 573.32 K | $14.55 M | -12.99% | 0.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/13/2026 | 509.79 K | $12.94 M | -55.12% | 0.81% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2026 | 502.08 K | $12.74 M | 0.00% | 0.80% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 08/13/2026 | 490.77 K | $12.46 M | -17.10% | 0.78% |
| NEXTBIO CAPITAL MANAGEMENT LP | 08/14/2026 | 426.74 K | $10.83 M | 0.00% | 0.68% |
| VESTAL POINT CAPITAL, LP | 08/14/2026 | 365.00 K | $9.26 M | 82.50% | 0.58% |
| MARSHALL WACE, LLP | 08/13/2026 | 323.44 K | $8.21 M | -35.56% | 0.51% |
| JENNISON ASSOCIATES LLC | 08/03/2026 | 314.05 K | $7.97 M | 25.62% | 0.50% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 304.87 K | $7.74 M | 21.26% | 0.48% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 302.09 K | $7.67 M | 34.62% | 0.48% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 302.09 K | $7.67 M | 100.00% | 0.48% |
| NORTHERN TRUST CORP | 08/13/2026 | 281.14 K | $7.14 M | 44.44% | 0.45% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 271.16 K | $6.88 M | -28.91% | 0.43% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 254.62 K | $6.46 M | 41.94% | 0.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 08/14/2026 | 230.83 K | $5.86 M | 7.70% | 0.37% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 226.20 K | $5.74 M | 84.05% | 0.36% |
| IA GLOBAL ASSET MANAGEMENT INC. | 07/29/2026 | 215.13 K | $5.46 M | -0.32% | 0.34% |
| WALLEYE CAPITAL LLC | 08/03/2026 | 209.05 K | $5.31 M | 66.93% | 0.33% |
| SIO CAPITAL MANAGEMENT, LLC | 08/14/2026 | 208.56 K | $5.29 M | -37.13% | 0.33% |
| CITADEL ADVISORS LLC | 09/02/2026 | 195.78 K | $4.97 M | 192.78% | 0.31% |
| UBS GROUP AG | 08/13/2026 | 178.09 K | $4.52 M | -51.53% | 0.28% |
| VOLEON CAPITAL MANAGEMENT LP | 08/14/2026 | 167.15 K | $4.24 M | 464.45% | 0.26% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 151.09 K | $3.83 M | 1,411.01% | 0.24% |
| MORGAN STANLEY | 08/13/2026 | 134.98 K | $3.43 M | 44.52% | 0.21% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 125.19 K | $3.18 M | 191.98% | 0.20% |
| BARCLAYS PLC | 08/14/2026 | 115.97 K | $2.94 M | 291.64% | 0.18% |
| SEVEN GRAND MANAGERS, LLC | 08/14/2026 | 100.00 K | $2.54 M | 0.00% | 0.16% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Zenas Biopharma Inc. institutional Ownership - FAQ's
During the previous two years, 174 institutional investors and hedge funds held shares of Zenas Biopharma Inc.. The most heavily invested institutionals were:
FMR LLC: 9.51 M
SR ONE CAPITAL MANAGEMENT, LP: 5.04 M
NEA Management Company, LLC: 4.02 M
Enavate Sciences GP, LLC: 3.92 M
FEDERATED HERMES, INC.: 3.12 M
BlackRock, Inc.: 2.69 M
97.56% of Zenas Biopharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 63.04 M shares in the last 24 months. This purchase volume represents approximately $1.65 B in transactions.